BMS-983970 is an oral pan- Notch inhibitor for the treatment of multiplecancers
In Vivo
BMS-983970 demonstrates anti-tumor activity in T-cell acute lymphoblastic leukemia (T-ALL) and solid tumor xenograft models . MCE has not independently confirmed the accuracy of these methods. They are for reference only.